Pancreatic Cancer section

Prostate Cancer News & Features

BRCA-related tumors respond to olaparib

Olaparib, an experimental oral cancer drug, has shown an overall tumor response rate of 26% in advanced cancers associated with BRCA1 and BRCA2 mutations, according to recent research.

Study investigating advanced MRI scans to detect prostate cancer set to begin

Study investigating advanced MRI scans to detect prostate cancer set to begin

A new technique that employs advanced MRI scans to diagnose prostate cancer is being tested in a nationwide trial.

Metformin use may be associated with decreased risk of prostate cancer

Metformin use may be associated with decreased risk of prostate cancer

Metformin use associated with decreased risk of prostate cancer diagnosis while other oral antihyperglycemics had no decreased risk.

Most internet sites on prostate cancer disagree with expert panel's recommendations

Most internet sites on prostate cancer disagree with expert panel's recommendations

Less than 20 percent of top-ranked health sites advise against screening for prostate cancer, a recommendation made by the USPSTF.

Active surveillance of prostate cancer leads to improved quality of life

Active surveillance of prostate cancer leads to improved quality of life

Active surveillance allows men with prostate cancer to delay or avoid the side effects of its treatment as well.

Prostate Cancer Videos

Prostate Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs